Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes - 48070 - unicondylar knee insert - sigma hp partial uni knee fixed bearing insert is a unicondylar insert manufactured of xlk uhmwpe and locks into the corresponding sigma hp partial tibial tray and articultes with the femoral component. sigma hp partial uni knee fixed bearing insert is the bearing component of the sigma high performance partial knee system and is intended to provide increased patient mobility and reduced pain by replacing the damaged knee joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. the sigma high performance partial knee system is indicated for single compartmental knee replacement in skeletally mature individuals with osteoarthritis, post-traumatic arthritis of the tibiofemoral articular surfaces or a history of gout or pseudogout.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - cefaclor monohydrate, quantity: 53.72 mg/ml (equivalent: cefaclor, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: methylcellulose; sodium lauryl sulfate; dimeticone 350; xanthan gum; tapioca starch; erythrosine; sucrose; flavour - aclor is indicated for the treatment of the following types of infections caused by or likely to be caused by susceptible organisms: lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis. upper respiratory tract infections, including pharyngitis, tonsillitis and otitis media. skin and skin structure infections. urinary tract infections including pyelonephritis and cystitis. note: 1. penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. aclor appears to be as effective as phenoxymethyl penicillin in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of aclor in the subsequent prevention of rheumatic fever are not available at present. 2. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefaclor.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famotidine, quantity: 40 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; purified talc; magnesium stearate; purified water; titanium dioxide; hypromellose; indigo carmine; quinoline yellow; iron oxide yellow; iron oxide red; macrogol 400 - duodenal ulcer; benign gastric ulcer; zollinger-ellison syndrome; prevention of relapses of duodenal ulceration; short-term (no more than 12 weeks) symptomatic relief of gastroesophageal reflux not responsive to conservative measures; healing of oesophageal erosion or ulceration associated with gastroesophageal reflux disease; prevention of relapses of symptoms and erosions or ulcerations associated with gastroesophageal reflux disease.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - famotidine, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; purified talc; magnesium stearate; purified water; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; iron oxide black; macrogol 400 - duodenal ulcer; benign gastric ulcer; zollinger-ellison syndrome; prevention of relapses of duodenal ulceration; short-term (no more than 12 weeks) symptomatic relief of gastroesophageal reflux not responsive to conservative measures; healing of oesophageal erosion or ulceration associated with gastroesophageal reflux disease; prevention of relapses of symptoms and erosions or ulcerations associated with gastroesophageal reflux disease.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes - 48070 - unicondylar knee insert - sigma hp partial uni knee fixed bearing insert is a unicondylar insert manufactured of xlk uhmwpe and locks into the corresponding sigma hp partial tibial tray and articulates with the femoral component. sigma hp partial uni knee fixed bearing insert is the bearing component of the sigma high performance partial knee system and is intended to provide increased patient mobility and reduced pain by replacing the damaged knee joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. the sigma high performance partial knee system is indicated for single compartmental knee replacement in skeletally mature individuals with osteoarthritis, post-traumatic arthritis of the tibiofemoral articular surfaces or a history of gout or pseudogout.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sigma aldrich pty ltd -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes - 32831 - uncoated knee femur prosthesis - the sigma ps150 femur is made from co-cr-mo alloy and intended for cemented use. the geometry of the femoral condylar component matches the sigma rpf tibial bearing component in the major load bearing positions of extension and stance phase flexion. the femoral components are available in right and left configurations. as part of total knee arthroplasty, the sigma ps150 rotating platform (rp) total knee system is indicated for cemented use in cases of osteoarthritis and rheumatoid arthritis.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes - 32831 - uncoated knee femur prosthesis - the sigma rp-f femoral components are manufactured from co-cr-mo alloy conforming to astm standard f-75. the geometry of the femoral condylar component matches the tibial bearing component in the major load bearing positions of extension and stance phase flexion. the femoral components are available in right and left configurations. the sigma rp-f femur is the femoral component of the p.f.c. sigma rp mobile bearing total knee system and is indicated for cemented use in cases of osteoarthritis and rheumatoid arthritis. the sigma rp-f femoral components are indicated where a higher than normal degree of post-operative flexion is required.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes - 46585 - prosthesis, knee, internal, insert component - the sigma rp-f tibial inserts are manufactured from uhmwpe and reinforced with astm f-90 co-cr-mo alloy pins. the sigma rp-f tibial inserts articulate with the sigma rp-f femoral component and m.b.t. primary and revision trays. the sigma rp-f tibial inserts are part of the lcs complete ? p.f.c. sigma rp mobile bearing total knee system and are indicated for use in cases of osteoarthritis and rheumatoid arthritis. the sigma rp-f inserts are indicated where a higher than normal degree of post-operative flexion is required.

Αυστραλία - Αγγλικά - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sigma chemicals (1986) pty. ltd. - chlorine present as trichloroisocyanuric acid - pool chlorine - swimming pool - outdoor - algae | bacteria